Elisha M Wachman, MD
Existing Patients
Make an appointment by phone
617.414.4363
Make an appointment with MyChart
Book with MyChart
New Patients
If you are a new patient and need an appointment, please contact us at the phone number below.
Learn more about coming to BMC. 617.414.4363Refer a Patient
Refer a patient
Call for assistance with the referral process
617.414.4363
More About Me
-
Administrative Title
Associate Professor of Pediatrics, Boston University Chobanian & Avedisian School of Medicine
Affiliations
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
As the principal teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center is devoted to training future generations of healthcare professionals. Learn more about Boston University Chobanian & Avedisian School of Medicine.
See my Boston University Chobanian & Avedisian School of Medicine profile
Featured on HealthCity
Can New Medication Formulations for Opioid Addiction Prevent Relapse in New Parents?
Opioid use has quadrupled in pregnancy, but effective medication options remain elusive for pregnant and breastfeeding persons.
Mandatory Reporting Law Is Harmful for Pregnant People with SUD
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
Placental Proteins Could Help Prevent COVID-19 Transmission
A less than 5% transmission rate in newborns suggests the placenta has properties that prevent COVID-19 infection.
ESC Model Improves Neonatal Opioid Withdrawal Syndrome Outcomes
The first multi-site study of the ESC model suggests a nonpharmacologic care model focused on maternal engagement is a safe option for widespread use.
Continued Naltrexone Use for OUD May Be Favorable in Pregnancy
New findings suggest that the understudied medication may lead to better short-term outcomes for some pregnant women with OUD and their babies.
An Improved Treatment Model for Neonatal Opioid Withdrawal
Study comparing two models of care shows benefits of symptom-triggered dosing over a fixed medication schedule.
